BANK OF MONTREAL /CAN/ - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 45 filers reported holding SECOND SIGHT MED PRODS INC in Q2 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q4 2017$1,0003800.0%0.00%
Q3 2017$03800.0%0.00%
Q2 2017$03800.0%0.00%
Q1 2017$0
-100.0%
380
-23.5%
0.00%
Q4 2016$1,000
-88.9%
497
-79.4%
0.00%
Q3 2016$9,000
-92.4%
2,417
-92.7%
0.00%
Q2 2016$118,000
+11700.0%
33,037
+13665.4%
0.00%
Q4 2015$1,000
-98.4%
240
-95.2%
0.00%
Q1 2015$64,0005,0000.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,492,975$8,536,653,0002.90%
Glassman Wealth Services 72,366$137,0000.06%
B. Riley Wealth Management, Inc. 53,500$102,0000.02%
Sigma Planning Corp 223,400$424,0000.02%
Fore Capital, LLC 40,000$76,0000.02%
Psagot Value Holdings Ltd. 218,555$415,0000.02%
HBK Sorce Advisory LLC 85,500$162,0000.02%
WealthTrust Axiom LLC 10,000$19,0000.01%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 12,894$24,0000.01%
Weiss Asset Management LP 29,691$56,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders